SPAG9 May Be a Potential Prognostic Marker of Endometrial Hyperplasia and Grade 1 Endometrioid Adenocarcinoma Treated with Progestin

Publisher： Karger

E-ISSN： 1423-002x|81|3|267-274

ISSN： 0378-7346

Source： Gynecologic and Obstetric Investigation, Vol.81, Iss.3, 2015-09, pp. : 267-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fractal Analysis of Surface Growth Patterns in Endometrioid Endometrial Adenocarcinoma

By  

Gynecologic and Obstetric Investigation, Vol. 58, Iss. 2, 2004-08 ,pp. : 61-67

Karger

Access to resources Recommend Favorite

Two Successful Pregnancies after in vitro Fertilization and Embryo Transfer in a Patient with Endometrial Atypical Hyperplasia Bordering on Adenocarcinoma Treated Conservatively with High-Dose Progesterone

By  

Gynecologic and Obstetric Investigation, Vol. 61, Iss. 1, 2006-01 ,pp. : 21-23

Karger

Access to resources Recommend Favorite

Atypical Endometrial Hyperplasia: Grounds for Possible Misdiagnosis of Endometrial Adenocarcinoma

By  

Gynecologic and Obstetric Investigation, Vol. 56, Iss. 3, 2003-11 ,pp. : 163-167

Karger

Access to resources Recommend Favorite

Assisted Reproductive Technologies in Conjunction with Conservatively Treated Endometrial Adenocarcinoma

By  

Gynecologic and Obstetric Investigation, Vol. 51, Iss. 3, 2001-04 ,pp. : 214-216

Karger

Access to resources Recommend Favorite

Endometrioid Adenocarcinoma Arising from Adenomyosis

By  

Gynecologic and Obstetric Investigation, Vol. 48, Iss. 2, 1999-08 ,pp. : 141-144

Karger

Access to resources Recommend Favorite